These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 37153571)
1. Biomaterials promote Qin YT; Li YP; He XW; Wang X; Li WY; Zhang YK Front Immunol; 2023; 14():1165576. PubMed ID: 37153571 [TBL] [Abstract][Full Text] [Related]
2. Biomaterials for chimeric antigen receptor T cell engineering. Niu H; Zhao P; Sun W Acta Biomater; 2023 Aug; 166():1-13. PubMed ID: 37137403 [TBL] [Abstract][Full Text] [Related]
3. Biomaterials in Chimeric Antigen Receptor T-Cell Process Development. Cardle II; Cheng EL; Jensen MC; Pun SH Acc Chem Res; 2020 Sep; 53(9):1724-1738. PubMed ID: 32786336 [TBL] [Abstract][Full Text] [Related]
4. Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors. Miao L; Zhang Z; Ren Z; Tang F; Li Y Front Immunol; 2021; 12():687822. PubMed ID: 34093592 [TBL] [Abstract][Full Text] [Related]
5. Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy. Nawaz W; Xu S; Li Y; Huang B; Wu X; Wu Z Acta Biomater; 2020 Jun; 109():21-36. PubMed ID: 32294554 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in biomaterial designs for assisting CAR-T cell therapy towards potential solid tumor treatment. Lin Y; Chen Y; Luo Z; Wu YL Nanoscale; 2024 Feb; 16(7):3226-3242. PubMed ID: 38284230 [TBL] [Abstract][Full Text] [Related]
7. Advanced Materials and Delivery Systems for Enhancement of Chimeric Antigen Receptor Cells. Li T; Luo R; Su L; Lv F; Mei L; Yu Y Small Methods; 2023 Nov; 7(11):e2300880. PubMed ID: 37653606 [TBL] [Abstract][Full Text] [Related]
8. Chimeric antigen receptor-engineered T-cell therapy for liver cancer. Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325 [TBL] [Abstract][Full Text] [Related]
9. Synthetic Biology in Chimeric Antigen Receptor T (CAR T) Cell Engineering. Zhang C; Zhuang Q; Liu J; Liu X ACS Synth Biol; 2022 Jan; 11(1):1-15. PubMed ID: 35005887 [TBL] [Abstract][Full Text] [Related]
10. Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy. Ruppel KE; Fricke S; Köhl U; Schmiedel D Front Immunol; 2022; 13():822298. PubMed ID: 35371071 [TBL] [Abstract][Full Text] [Related]
11. Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors. Yu T; Yu SK; Xiang Y; Lu KH; Sun M Front Immunol; 2022; 13():936496. PubMed ID: 35903099 [TBL] [Abstract][Full Text] [Related]
12. Current Challenges and Strategies for Chimeric Antigen Receptor-T-Cell Therapy for Solid Tumors. Chen J; Jiang H Crit Rev Immunol; 2021; 41(1):1-12. PubMed ID: 33822521 [TBL] [Abstract][Full Text] [Related]
13. CAR-T Cell Therapy: Challenges and Optimization. Luo M; Zhang H; Zhu L; Xu Q; Gao Q Crit Rev Immunol; 2021; 41(1):77-87. PubMed ID: 33822526 [TBL] [Abstract][Full Text] [Related]
14. Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer. Kandra P; Nandigama R; Eul B; Huber M; Kobold S; Seeger W; Grimminger F; Savai R Front Immunol; 2022; 13():903562. PubMed ID: 35720364 [TBL] [Abstract][Full Text] [Related]
15. Chimeric antigen receptor T cell therapy and other therapeutics for malignancies: Combination and opportunity. Wang L; Yao R; Zhang L; Fan C; Ma L; Liu J Int Immunopharmacol; 2019 May; 70():498-503. PubMed ID: 30875561 [TBL] [Abstract][Full Text] [Related]
16. Gene modification strategies for next-generation CAR T cells against solid cancers. Tian Y; Li Y; Shao Y; Zhang Y J Hematol Oncol; 2020 May; 13(1):54. PubMed ID: 32423475 [TBL] [Abstract][Full Text] [Related]
17. In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors. Sun Z; Li R; Shen Y; Tan S; Ding N; Xu R; Wang X; Wei J; Liu B; Meng F J Hematol Oncol; 2022 Mar; 15(1):29. PubMed ID: 35303900 [TBL] [Abstract][Full Text] [Related]
18. Making CAR T Cells a Solid Option for Solid Tumors. Schmidts A; Maus MV Front Immunol; 2018; 9():2593. PubMed ID: 30467505 [TBL] [Abstract][Full Text] [Related]
19. Radiotherapy to Enhance Chimeric Antigen Receptor T-Cell Therapeutic Efficacy in Solid Tumors: A Narrative Review. Hauth F; Ho AY; Ferrone S; Duda DG JAMA Oncol; 2021 Jul; 7(7):1051-1059. PubMed ID: 33885725 [TBL] [Abstract][Full Text] [Related]
20. Harmonizing the symphony of chimeric antigen receptor T cell immunotherapy with the elegance of biomaterials. Chen Z; Hu Y; Mei H Trends Biotechnol; 2024 Aug; ():. PubMed ID: 39181760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]